CPG companies are lowering sodium content, including through stealth-health, while larger market trends around clean-label might be distracting companies for developing healthier and more nutritious ...
ANN ARBOR, Mich., March 22, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for ...
Esperion presented positive results for bempedoic acid in reducing major adverse cardiovascular events and heart attacks compared to a placebo, and plans to file for expanded labels this year. However ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback